Merrimack Pharma (MACK) Presents Additional Analyses of Phase 3 MM-398 NAPOLI-1 at ASCO
Tweet Send to a Friend
Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) announced that additional analyses were presented on January 16, 2015 from the Phase 3 NAPOLI-1 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
